These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31092552)

  • 1. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
    Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
    Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α
    Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status.
    Fumagalli A; Zarca A; Neves M; Caspar B; Hill SJ; Mayor F; Smit MJ; Marin P
    Mol Pharmacol; 2019 Dec; 96(6):794-808. PubMed ID: 30837297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
    Evans AE; Tripathi A; LaPorte HM; Brueggemann LI; Singh AK; Albee LJ; Byron KL; Tarasova NI; Volkman BF; Cho TY; Gaponenko V; Majetschak M
    Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein activation via chemokine (C-X-C motif) receptor 4 and α
    Gao X; Majetschak M
    FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
    Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
    J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists.
    Szpakowska M; Meyrath M; Reynders N; Counson M; Hanson J; Steyaert J; Chevigné A
    Biochem Pharmacol; 2018 Jul; 153():299-309. PubMed ID: 29530506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
    Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
    Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulators of CXCR4 and CXCR7/ACKR3 Function.
    Adlere I; Caspar B; Arimont M; Dekkers S; Visser K; Stuijt J; de Graaf C; Stocks M; Kellam B; Briddon S; Wijtmans M; de Esch I; Hill S; Leurs R
    Mol Pharmacol; 2019 Dec; 96(6):737-752. PubMed ID: 31548340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
    Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
    Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
    Schafer CT; Chen Q; Tesmer JJG; Handel TM
    Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements.
    Doijen J; Van Loy T; De Haes W; Landuyt B; Luyten W; Schoofs L; Schols D
    PLoS One; 2017; 12(9):e0185354. PubMed ID: 28945785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
    Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway.
    Ma Z; Zhou F; Jin H; Wu X
    Cells; 2024 Jun; 13(12):. PubMed ID: 38920657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells.
    Neves M; Marolda V; Mayor F; Penela P
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
    Duval V; Alayrac P; Silvestre JS; Levoye A
    Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
    Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
    J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.